Vertex Presents Positive Long-Term Data On CASGEVY⢠(exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update
– Data from long-term follow-up of patients in clinical trials further demonstrate durability of the...

